Clinical Trial Update: Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glimeperide Administration in Type 2 DM [NA]

View source ↗

Summary

The document provides a clinical trial update examining how insulin secretory parameters respond to sitagliptin and glimepiride in individuals with type 2 diabe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Amaryl (glimepiride)
• Januvia (sitagliptin)

Snippet

Sponsor: Foundation for the National Institutes of Health | Conditions: Type 2 Diabetes | NA | Status: UNKNOWN